MedTrace Logo

Predictors of Malnutrition in Patients With Haematological Cancer

NCT05209321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2022-11-04

No results posted yet for this study

Summary

The primary purpose of this study is to conduct an exploratory study of which predictors are most significant for LBM loss in patients with lymphoma. Patients are measured by weight and bio impedance and furthermore, their physical activity, nutritional status, diet and quality of life during the course are estimated. This is done in order to determine any changes in the aforementioned factors during the course of the cancer treatment that may have a bearing on the loss of LBM.

Conditions

Sponsors & Collaborators

  • Jens Rikardt Andersen

    lead OTHER

Principal Investigators

  • Jens R Andersen, MD,MPA · University of Copenhagen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-07-15
Completion
2021-10-04

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05209321 on ClinicalTrials.gov